Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
PolyTherics
PolyTherics
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Antitope to produce cell line for Baylor Institute
For novel therapeutic dendritic-cell-targeting vaccine
Finance
PolyTherics merges with Antitope
London-based biopharmaceuticals developer also receives new investment to accelerate growth
Ingredients
PolyTherics extends application of PolyPEG to more companies
Extension of collaboration will investigate further applications of patented polymer
Research & Development
PolyTherics and Spirogen announce research collaboration
To develop novel antibody drug conjugates for the treatment of cancer
Research & Development
PolyTherics acquires Warwick Effect Polymers
Expands polyethylene glycol (PEG) technology portfolio
Research & Development
PolyTherics receives grant to develop novel fusion proteins
Project aims to develop a way of fusing proteins that is quicker and cheaper
Research & Development
PolyTherics wins funding to further PEGylation development
PolyTherics, a UK user of biomedical polymers to optimise pharmaceuticals, has completed an investment round of
Subscribe now